These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 3682335

  • 1. [Thromboxane A2 metabolism and clinical effects of selective thromboxane A2 synthetase inhibitor in patients with chronic glomerulonephritis].
    Niwa T, Nomura T, Ozawa Y, Maeda K, Shibata M.
    Nihon Jinzo Gakkai Shi; 1987 Jun; 29(6):655-65. PubMed ID: 3682335
    [No Abstract] [Full Text] [Related]

  • 2. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T, Maeda K, Shibata M, Yamada K.
    Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
    [Abstract] [Full Text] [Related]

  • 3. [Effects of a selective thromboxane A2 synthetase inhibitor, OKY-046, on proteinuria of aminonucleoside nephrotic rats].
    Suzuki S, Akama H, Kume K, Higuchi E, Kamiyama S, Suzuki J, Ohara N, Yugeta E, Kato K, Suzuki H.
    Nihon Jinzo Gakkai Shi; 1988 Apr; 30(4):341-6. PubMed ID: 3230687
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of occlusive cerebrovascular disease with a selective thromboxane A2 synthetase inhibitor].
    Okamoto S, Yonekawa Y, Handa H, Handa Y, Uemura Y, Yano I, Toyoshima M, Iwatsuji K, Teraura T, Yamagata S.
    Nihon Geka Hokan; 1986 Jan 01; 55(1):251-9. PubMed ID: 3741043
    [No Abstract] [Full Text] [Related]

  • 5. [Prevention of vasospasm following subarachnoid hemorrhage using a thromboxane A2 synthetase inhibitor (OKY-046)--clinical study among multiple institutions].
    Yonekawa Y, Handa H, Okamoto S, Ohta T, Kamijo Y, Oda Y, Kondo A, Nin K, Yamamoto T, Ban S.
    Nihon Geka Hokan; 1986 May 01; 55(3):473-84. PubMed ID: 3541826
    [No Abstract] [Full Text] [Related]

  • 6. [Experimental study on the prevention of vasospasm following subarachnoid hemorrhage by a thromboxane A2 synthetase inhibitor, OKY-046].
    Ohsugi S.
    Nihon Geka Hokan; 1986 Mar 01; 55(2):297-305. PubMed ID: 3827476
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of selective thromboxane synthetase inhibitor OKY-046 on plasma prostaglandins in patients with coronary artery disease during exercise.
    Shikano M, Ogawa K, Ito T, Chen LS, Ito Y, Imaizumi M, Uno T, Tsutsumi S, Satake T.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Mar 01; 13():375-7. PubMed ID: 3159226
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of thromboxane A2-synthetase inhibitor OKY-046 and evening primrose oil (Efamol) on mercuric chloride induced autoimmune glomerulonephritis in Brown-Norway rats.
    Papanikolaou N, Hatziantoniou C, Gkika EL.
    Prog Clin Biol Res; 1987 Mar 01; 242():43-9. PubMed ID: 3671393
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Chronic persistent coughing successfully treated with ozagrel].
    Nishi K, Mizuguchi M, Tachibana H, Ooka T, Fujimura M, Matsuda T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar 01; 34(3):350-4. PubMed ID: 8778479
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K, Takagi K, Horiba M.
    Nihon Rinsho; 1996 Nov 01; 54(11):3034-9. PubMed ID: 8950950
    [Abstract] [Full Text] [Related]

  • 19. Augmented thromboxane A2 generation and efficacy of its blockade in acute myocardial infarction.
    Tada M, Hoshida S, Kuzuya T, Inoue M, Minamino T, Abe H.
    Int J Cardiol; 1985 Jul 01; 8(3):301-12. PubMed ID: 4040500
    [Abstract] [Full Text] [Related]

  • 20. [The efficacy of prostacyclin (PGI2) and/or OKY-046, a specific thromboxane synthetase inhibitor, in acute myocardial infarction--experimental study].
    Moriuchi M.
    Kokyu To Junkan; 1984 Sep 01; 32(9):955-61. PubMed ID: 6393261
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.